New Delhi: Medication Controller General India (DCGI) has given approval to conduct a study of mixing covaxin and covishield vaccines.
The research study will be carried out by Christian Medical College, Vellore, said Dr.
V K Paul, Niti Aayog during the press direction on Tuesday.
Previously, the Indian Medical Research Council (ICMR) has revealed in his research that the combination of Covaxin and Covishield vaccines, two main vaccines of the Covid-19 vaccination program, which was carried out in 18 people, had caused better safety and immunogenicity.
In this study, ICMR compares the profile of salvation and immunogenicity with individuals who receive covaxin or covishield and it shows better results.
The current national vaccination program has entered the fourth month of its existence and the event of a mixed dose gathered a large enough anxiety in the public domain with the potential to contribute to vaccine doubts.
This study was conducted on this background.
So, including this 18 people who have received a dose of covishield and the second dose of Covaxin, 40 recipients of two covishield doses and 40 recipients of two covaxin doses, were recruited in this study.
The duration of the study came from May to June 2021.
(with agency input)
DCGI approved the study of mixing Covaxin, Covishield
